Table 5. Monthly costs of Crohn’s disease in Poland.

Category, number of respondents	Mean cost per respondent (SD)
I. Indirect costs
Absenteeism, n = 197	€110.86 (286.29)
Registered early departure from labour market, n = 197	€162.04 (434.45)
Presenteeism, n = 197	€139.62 (224.73)
Productivity loss at unpaid work, n = 195	€49.95 (116.71)
Informal care, n = 195	€48.26 (112.41)
II. Direct costs
Publicly funded consultation with specialist, n = 196	€6.62 (9.25)
Private consultation with specialist, n = 196	€16.62 (30.99)
Hospitalisations—public payer’s perspective, n = 194	€202.11 (496.82)
Current treatment—public payer’s perspective, n = 200	€173.31 (382.31)
All medications prescribed or recommended by physicians (patients’ perspective), n = 197	€45.25 (36.98) a
Dietary supplements, special diet, special equipment, transportation to the medical facility (patients’ perspective), n = 193	€34.64 (35.70) b
Informational materials, additional hygienic articles and others (patients’ perspective), n = 194	€13.97 (8.93) c
III. Transfer costs
Social benefits or financial support from public organisations, n = 196	€39.73 (88.19)
Financial support from others, n = 195	€14.83 (50.46)

^a the maximal relative measurement uncertainty ranged from -37.8% to 20.8% of presented value;

^b as above, from -43.2% to 30.9%;

^c as above, from -85.2% to 82.7%